Document Detail


Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromsø Study 2001.
MedLine Citation:
PMID:  17825547     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Bronchial airflow limitation is a known predictor of raised C-reactive protein (CRP) level. The aim of this study was to explore this association in an elderly population, as well as the influence of other known and possible predictors of the CRP level, like smoking and the use of statins and inhaled corticosteroids. POPULATION AND METHODS: The study population consists of 3877 Norwegians aged 60 years or more who took part in the fifth Tromsø study in 2001, a cross-sectional study. The examinations included questionnaires, spirometry and the measurement of CRP. RESULTS: A geometric mean CRP value of 3.15 mg/L was found in subjects with severe airflow limitation (FEV(1)%<50 predicted and FEV(1)/FVC<70%), compared to 1.64 mg/L in subjects with normal spirometry, (p<0.001), and 19% of the subjects with severe airflow limitation had a CRP value above 10 mg/L compared to 4.9% in those with mild airflow limitation or normal spirometry. Elevated body mass index (BMI), smoking, hormone replacement therapy, and increasing age, were also strong independent predictors of increased CRP. Statin use was a strong predictor of decreased CRP level, while the use of inhaled corticosteroids was not associated with decreased CRP values. CONCLUSION: We found a strong link between bronchial airflow limitation and the circulating CRP level in an elderly population, independent of self-reported diseases, medication, smoking, and elevated BMI. The CRP value increased with increasing age in men, but not in women, which may be partly explained by a greater impact of chronic obstructive pulmonary disease (COPD) morbidity on the CRP level in men than in women. Measuring CRP may show to be a useful part of the diagnostic work-up in COPD patients.
Authors:
Hasse Melbye; Dag S Halvorsen; Ingeborg Hartz; Astri Medbø; Jan Brox; Anne Elise Eggen; Inger Njølstad
Related Documents :
15919777 - Smoking habits of parents and male: female ratio in spermatozoa and preimplantation emb...
7183197 - Cigarette smoking, manifest anxiety and somatic symptoms.
10609977 - Eeg, physiology, and task-related mood fail to resolve across 31 days of smoking abstin...
3733117 - Theophylline pharmacokinetics in patients from a geriatric hospital: influence of cigar...
17367977 - Study of the photostability of 18 sunscreens in creams by measuring the spf in vitro.
16436397 - A randomised control study of a fully automated internet based smoking cessation progra...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-09-06
Journal Detail:
Title:  Respiratory medicine     Volume:  101     ISSN:  0954-6111     ISO Abbreviation:  Respir Med     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-10-30     Completed Date:  2008-02-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  2541-9     Citation Subset:  IM    
Affiliation:
Institute of Community Medicine, University of Tromso, 9037 Tromso, Norway. hasse.melbye@ism.uit.no
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Age Factors
Aged
Biological Markers / blood
Body Mass Index*
Bronchoconstriction / physiology*
C-Reactive Protein / analysis*
Case-Control Studies
Estrogen Replacement Therapy
Female
Glucocorticoids / administration & dosage
Health Surveys
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Male
Middle Aged
Multivariate Analysis
Norway
Pulmonary Disease, Chronic Obstructive / blood*,  physiopathology
Sex Factors
Smoking / adverse effects*
Spirometry
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Glucocorticoids; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Physical fatty acid deficiency signs in children with ADHD symptoms.
Next Document:  Modelling of stable isotope fractionation by methane oxidation and diffusion in landfill cover soils...